Mifepristone (also known as RU-486), a progesterone receptor antagonist displaying also high affinity to GR, was shown to reduce depressive symptoms in patients with psychotic depression and bipolar disorder [75, 76], however serious side effects associated with long-term treatment are discouraging for therapeutic use in psychiatry [65]. Here, NR3C1 is linked to major depressive disorder.